History of pneumonia is a strong risk factor for chronic obstructive pulmonary disease (COPD) exacerbation in South Korea: The Epidemiologic review and Prospective Observation of COPD and Health in Korea (EPOCH) study

Journal of Thoracic Disease

Volumn 7, Issue 12, 2015, Pages 2203-2213

  Hwang, Yong Il ^a   Lee, Sang Haak ^b   Yoo, Jee Hong ^c   Jung, Bock Hyun ^d   Yoo, Kwang Ha ^e   Na, Moon Jun ^f   Lee, Jong Deog ^g   Park, Myung Jae ^c   Jung, Chi Young ^h   Shim, Jae Jeong ⁱ   Kim, Kyung Chan ^j   Kim, Yeon Jae ^k   Choi, Hye Sook ^l   Choi, Ik Su ^m   Lee, Choon Taek ⁿ   Lee, Sang Do ^o   Kim, Do Jin ^p   Uh, Soo Taek ^p   Lee, Ho Sung ^p   Kim, Young Sam ^q   Lee, Kwan Ho ^r   Ra, Seung Won ^s   Kim, Hak Ryul ^t   Choi, Soo Jeon ^u   Park, In Won ^v   Park, Yong Bum ^a   Park, So Young ^a   Lee, Jaehee ^w   Jung, Ki Suck ^a   more..

^a Hallym University   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Kyung Hee University College of Medicine   (South Korea)

^d Gangneung Asan Hospital   (South Korea)

^e Konkuk University Hospital   (South Korea)

^f Konyang University College of Medicine   (South Korea)

^g Gyeongsang National University   (South Korea)

^h Dongsan Medical Center   (South Korea)

ⁱ Korea University College of Medicine   (South Korea)

^j Catholic University of Daegu   (South Korea)

^k Daegu Fatima Hospital   (South Korea)

^l Dongguk University Gyeongju Hospital   (South Korea)

^m Maryknoll Hospital   (South Korea)

ⁿ Seoul National University Bundang Hospital   (South Korea)

^o Asan Medical Center   (South Korea)

^p Soonchunhyang University   (South Korea)

^q Yonsei University College of Medicine   (South Korea)

^r Yeungnam University Hospital   (South Korea)

^s University of Ulsan College of Medicine   (South Korea)

^t Wonkwang University   (South Korea)

^u Inje University College of Medicine   (South Korea)

^v Chung Ang University College of Medicine   (South Korea)

^w Kyungpook National University Hospital   (South Korea)

more..

Author keywords

Chronic bronchitis; Chronic obstructive pulmonary disease (COPD); Exacerbation; Pneumonia; South Korea

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LONG ACTING DRUG; MUSCARINIC RECEPTOR BLOCKING AGENT; SHORT ACTING DRUG;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL STUDY; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE EXACERBATION; EXPERIENCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFORMATION PROCESSING; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBSERVATIONAL STUDY; PHENOTYPE; PNEUMONIA; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK FACTOR; SOUTH KOREA; SPIROMETRY; UNIVARIATE ANALYSIS;

EID: 84954151062     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.3978/j.issn.2072-1439.2015.12.17     Document Type: Article

References (16)

1. World Health Organization. World Health Report 2000: health systems: improving performance. Geneva, Switzerland, 2000.
2. Ko FW, Lim TK, Hancox RJ, et al. Year in review 2013: Chronic obstructive pulmonary disease, asthma and airway biology. Respirology 2014;19:438-47.
3. Yoo KH, Kim YS, Sheen SS, et al. Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and Nutrition Examination Survey, 2008. Respirology 2011;16:659-65.
4. Soler-Cataluña JJ, Martínez-García MA, Román Sánchez P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005;60:925-31.
5. Wedzicha JA, Donaldson GC. Exacerbations of chronic obstructive pulmonary disease. Respir Care 2003;48:1204-13; discussion 1213-5.
6. Arostegui I, Esteban C, García-Gutierrez S, et al. Subtypes of patients experiencing exacerbations of COPD and associations with outcomes. PLoS One 2014;9:e98580.
7. Roede BM, Bindels PJ, Brouwer HJ, et al. Antibiotics and steroids for exacerbations of COPD in primary care: compliance with Dutch guidelines. Br J Gen Pract 2006;56:662-5.
8. de Oca MM, Tálamo C, Halbert RJ, et al. Frequency of self-reported COPD exacerbation and airflow obstruction in five Latin American cities: the Proyecto Latinoamericano de Investigacion en Obstruccion Pulmonar (PLATINO) study. Chest 2009;136:71-8.
9. Langsetmo L, Platt RW, Ernst P, et al. Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J Respir Crit Care Med 2008;177:396-401.
10. Suissa S, Dell'Aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax 2012;67:957-63.
11. Jones PW. COPD assessment test-rationale, development, validation and performance. COPD 2013;10:269-71.
12. Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J Suppl 2003;41:46s-53s.
13. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (updated 2010). Available online: http://www.goldcopd.org/uploads/users/files/GOLDReport_April112011.pdf
14. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (updated 2011). Available online: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2011_Feb21.pdf
15. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010;363:1128-38.
16. Roberts CM, Buckingham RJ, Pursey NA, et al. (Clinical Effectiveness and Evaluation unit, Royal College of Physicians of London). The National Chronic Obstructive Pulmonary Disease Resources and Outcomes Project (NCROP) Final Report. Royal College of Physicians of London, British Thoracic Society and British Lung Foundation; 2009 May.